<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Handling Missing Modalities in Multimodal Survival Prediction for Non-Small Cell Lung Cancer - Health AI Hub</title>
    <meta name="description" content="Accurate survival prediction in Non-Small Cell Lung Cancer (NSCLC) requires the integration of heterogeneous clinical, radiological, and histopathological infor">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Handling Missing Modalities in Multimodal Survival Prediction for Non-Small Cell Lung Cancer</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2601.10386v1" target="_blank">2601.10386v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2026-01-15
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Filippo Ruffini, Camillo Maria Caruso, Claudia Tacconi, Lorenzo Nibid, Francesca Miccolis, Marta Lovino, Carlo Greco, Edy Ippolito, Michele Fiore, Alessio Cortellini, Bruno Beomonte Zobel, Giuseppe Perrone, Bruno Vincenzi, Claudio Marrocco, Alessandro Bria, Elisa Ficarra, Sara Ramella, Valerio Guarrasi, Paolo Soda
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV, cs.AI, cs.MM
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2601.10386v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2601.10386v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">Accurate survival prediction in Non-Small Cell Lung Cancer (NSCLC) requires the integration of heterogeneous clinical, radiological, and histopathological information. While Multimodal Deep Learning (MDL) offers a promises for precision prognosis and survival prediction, its clinical applicability i...</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Medical/health related research</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>Development of an AI-powered multimodal survival prediction framework for Non-Small Cell Lung Cancer. This application aims to provide more accurate patient prognoses by integrating diverse medical data types (CT scans, pathology slides, clinical variables), thereby assisting clinicians in treatment planning and patient management, especially when confronted with incomplete data.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>See abstract for details</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>See paper for methodology</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>See abstract</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>Potential clinical applications</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>Not analyzed</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Not analyzed</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">cs.CV</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">cs.CV</span>
                    
                    <span class="tag tag-keyword">cs.AI</span>
                    
                    <span class="tag tag-keyword">cs.MM</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Accurate survival prediction in Non-Small Cell Lung Cancer (NSCLC) requires the integration of heterogeneous clinical, radiological, and histopathological information. While Multimodal Deep Learning (MDL) offers a promises for precision prognosis and survival prediction, its clinical applicability is severely limited by small cohort sizes and the presence of missing modalities, often forcing complete-case filtering or aggressive imputation. In this work, we present a missing-aware multimodal survival framework that integrates Computed Tomography (CT), Whole-Slide Histopathology (WSI) Images, and structured clinical variables for overall survival modeling in unresectable stage II-III NSCLC. By leveraging Foundation Models (FM) for modality-specific feature extraction and a missing-aware encoding strategy, the proposed approach enables intermediate multimodal fusion under naturally incomplete modality profiles. The proposed architecture is resilient to missing modalities by design, allowing the model to utilize all available data without being forced to drop patients during training or inference. Experimental results demonstrate that intermediate fusion consistently outperforms unimodal baselines as well as early and late fusion strategies, with the strongest performance achieved by the fusion of WSI and clinical modalities (73.30 C-index). Further analyses of modality importance reveal an adaptive behavior in which less informative modalities, i.e., CT modality, are automatically down-weighted and contribute less to the final survival prediction.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>